Evidence map›Paper›PMID 31131330›Full record

ArticleJacobs journal of addiction and therapy2018

Survey of Treatment Preferences for Opioid Use Disorder.

Ravi Nahata, Michael J Mancino, Jeff Thostenson, Alison H Oliveto

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Jacobs journal of addiction and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ravi NahataDivision of Mental Health Service, Central Arkansas Veterans Healthcare System, 2200 Fort Roots Drive, Bldg. 170, Rm. 3L 105, North Little Rock, AR 72114.
Michael J MancinoDepartment of Psychiatry, University of Arkansas for Medical Sciences, 4301 W Markham Street, Little Rock, AR 72205, USA.
Jeff ThostensonDepartment of Biostatistics, University of Arkansas for Medical Sciences, 4301 W Markham Street, Little Rock, AR 72205, USA.
Alison H OlivetoDepartment of Psychiatry, University of Arkansas for Medical Sciences, 4301 W Markham Street, Little Rock, AR 72205, USA.
University of Arkansas for Medical Sciences · US

Funding

Improving Treatment Outcomes for Prescription Opioid DependenceR01DA039088 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI MANCINO, MICHAEL J, OLIVETO, ALISON · 2015 to 2019
$2.9M
Improving Buprenorphine Detoxification Outcomes with IsradipineR21DA035325 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI OLIVETO, ALISON · 2013 to 2014
$406k
NIDA NIH HHS R01 DA039088NIDA NIH HHS R21 DA035325
6 · The paper itself

Abstract

objectivesThis study gathered preliminary information on the initial feasibility of using injection Naltrexone (NTX) therapy in opioid users.

methodsOne hundred opioid users (36% female, 8% minorities, mean age 34.5±11.4 yrs.) undergoing a health screen to determine initial eligibility for an ongoing study completed the survey.

resultsOf the 100 respondents, 26, 16, 16, 1 and 0 reported prior treatment episodes of opioid detoxification, buprenorphine (BUP), methadone (MTD), oral NTX and injection NTX, respectively. Ninety and 71% were interested in participating in a study involving oral and/or injection NTX treatment, respectively. Reasons for not wanting to try injection NTX included fear of needles (n=13), side effects (n=7), lack of pain relief (n=12) and cost (n=3). A significantly higher percentage of those interested in injection NTX had episodes of prior opioid agonist maintenance treatment relative to those uninterested (32.4% vs 10.3%; Chi

conclusionsThese preliminary results suggest that those with prior, failed experience with opioid agonist maintenance treatment are more likely to consider injection NTX therapy, suggesting it may be optimal as a second-line treatment for OUD.

Indexed as

Naltrexoneopioid use disorderprescription opioids

Identifiers

PMID31131330
PMCPMC6530927
OpenAlexW2994043240

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.